4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0001209191-23-011790
Chief Financial Officer gave up 1,392 shares (to pay taxes)
- Chief Financial Officer acquired 3,825 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Smith Brendan Chief Financial Officer | 2023-02-18 | Option exercise | +3,825 | 6,464 | D | ||
| Smith Brendan Chief Financial Officer | 2023-02-21 | Shares withheld for taxes | −1,392 | $48.26 | $67,178 | 5,072 | D |
| Derivatives | |||||||
| Smith Brendan Chief Financial Officer | 2023-02-18 | Option exercise · Restricted Stock Units | −3,825 | 11,475 | D | ||
Loading xslF345X03/doc4.xml…